This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Verseau Therapeutics, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Brian O'Nuallain: Innovator in Myeloid Cell Modulation
Introduction
Brian O'Nuallain is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of myeloid cell inflammatory phenotypes. His work is crucial for advancing therapeutic strategies in various inflammatory diseases.
Latest Patents
O'Nuallain holds a patent titled "Anti-PSGL-1 Compositions and Methods for Modulating Myeloid Cell Inflammatory Phenotypes and Uses Thereof." This patent represents his innovative approach to addressing inflammation at the cellular level. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Currently, Brian O'Nuallain is associated with Verseau Therapeutics, Inc., where he continues to develop groundbreaking therapies. His role at the company allows him to collaborate with other experts in the field and contribute to the development of novel treatments.
Collaborations
Throughout his career, O'Nuallain has worked alongside talented individuals such as Igor Feldman and Ryan Phennicie. These collaborations have fostered a dynamic environment for innovation and research.
Conclusion
Brian O'Nuallain is a dedicated inventor whose work in myeloid cell modulation is paving the way for new therapeutic options. His contributions to the field are invaluable and reflect his commitment to improving human health.